Appendix cancer, also called appendiceal cancer, is when abnormal cells grow and form a tumor in the appendix. Your appendix is a little pouch-like organ attached to the lower right side of your large ...

Appendix cancer, a rare condition originating in the appendix, is showing a rise in reported cases. While often discovered incidentally, improved diagnostics and potential lifestyle factors contribute ...

Just when we thought we had enough on our medical to-do list—Pap smears, mammograms, cholesterol checks, stress management, hydration, posture—now we’re hearing that appendix cancer is on the rise?

A misdiagnosis of fibroid tumors led to the discovery of appendix cancer that spread to the ovary and uterus, requiring ...

Appendix cancer, once considered rare, is increasingly affecting younger adults, particularly those born since the 1970s. Research indicates a three to fourfold increase in diagnoses compared to older ...

Cases of appendix cancer appear to be rising among Gen X and millennials, according to a new study that found those age groups are three times more likely to face a diagnosis than their parents. The ...

The place where a cancer starts in the body is called the primary cancer or primary site. Cells from the primary site may break away and spread to other parts of the body. These cells can then grow ...

Prostate cancer (castrate-resistant) - denosumab (bone metastasis): appendix B - draft scope for consultation (pre-referral) July 2011 Prostate cancer (castrate-resistant) - denosumab (bone metastasis ...

Appendix cancer once had a reputation as one of the rarest forms of cancer. Many were unaware of the condition entirely. And when doctors did encounter it, it was almost exclusively in older people ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Bone metastases (hormone refractory prostate cancer) - denosumab: response to comments on the draft scope and provisional matrix Bone metastases (hormone refractory prostate cancer) - denosumab: ...